Vicarious Surgical (RBOT) Stock Price, News & Analysis

Company Overview

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology. In addition to the robotic hardware and VR interface, Vicarious Surgical provides comprehensive training programs, service contracts and remote support tools to help hospitals and surgical centers integrate its system into existing clinical workflows. The company has conducted early-stage clinical evaluations under FDA investigational device exemptions and is pursuing full regulatory clearance in the United States, with plans to seek approvals in key international markets upon U.S. authorization.

Founded in 2014 and headquartered in Boston, Massachusetts, Vicarious Surgical was co-founded by Dr. Adam Sachs, who serves as chief executive officer, and Dr. Justin Ryan, who oversees technology development as chief technology officer. The leadership team combines expertise in robotic engineering, software development and minimally invasive surgery, supported by a board that includes experienced healthcare and medical device executives.

After completing preclinical and feasibility studies, the company went public through a merger with a special purpose acquisition company in late 2021 and trades on the New York Stock Exchange under the ticker RBOT. With a focus on expanding clinical evidence and scaling its commercial infrastructure, Vicarious Surgical aims to bring its VR-enhanced robotic platform into broader surgical practice in the years ahead.

Key Stats

• Today's Range: $5.75 to $6.61
• 50-Day Range: $5.38 to $10.31
• 52-Week Range: $5.00 to $19.00
• Volume: 89,501 shs
• Average Volume: 37,899 shs
• Market Capitalization: $34.63 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.00
• Consensus Rating: Reduce

Vicarious Surgical Stock Analysis - MarketRank™

Vicarious Surgical scored higher than 42% of companies evaluated by MarketBeat, and ranked 830th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.7 / 5
• Analyst Rating: Reduce

Consensus Rating

Vicarious Surgical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Vicarious Surgical has a consensus price target of $7.00, representing about 19.9% upside from its current price of $5.84.

Amount of Analyst Coverage

Vicarious Surgical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Vicarious Surgical is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Vicarious Surgical is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Vicarious Surgical has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.30% of the outstanding shares of Vicarious Surgical have been sold short.

Short Interest Ratio / Days to Cover

Vicarious Surgical has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Vicarious Surgical has recently increased by 4.92%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Vicarious Surgical does not currently pay a dividend.

Dividend Growth

Vicarious Surgical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.30% of the outstanding shares of Vicarious Surgical have been sold short.

Short Interest Ratio / Days to Cover

Vicarious Surgical has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Vicarious Surgical has recently increased by 4.92%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.20

News Sentiment

Vicarious Surgical has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Vicarious Surgical this week, compared to 1 article on an average week.

MarketBeat Follows

2 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $44,454.00 in company stock.

Percentage Held by Insiders

11.99% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RBOT Stock Analysis - Frequently Asked Questions

How have RBOT shares performed this year?

Vicarious Surgical's stock was trading at $13.16 at the beginning of 2025. Since then, RBOT shares have decreased by 55.6% and is now trading at $5.84.

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc. (NYSE:RBOT) issued its earnings results on Tuesday, August, 12th. The company reported ($2.23) earnings per share for the quarter, beating analysts' consensus estimates of ($2.61) by $0.38.
Read the conference call transcript.

When did Vicarious Surgical's stock split?

Vicarious Surgical shares reverse split before market open on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Vicarious Surgical?

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vicarious Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

• Last Earnings: 8/12/2025
• Today: 10/10/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:RBOT
• CIK: 1812173
• Web: www.vicarioussurgical.com
• Phone: 617 868 1700
• Fax: N/A
• Employees: 210
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Vicarious Surgical: $7.00
• High Price Target: $7.00
• Low Price Target: $7.00
• Potential Upside/Downside: +19.9%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($10.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$63.22 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -148.14%
• Return on Assets: -98.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.11
• Quick Ratio: 5.11

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.89 per share
• Price / Book: 0.74

Miscellaneous

• Outstanding Shares: 5,930,000
• Free Float: 5,220,000
• Market Cap: $34.63 million
• Optionable: No Data
• Beta: 1.38